MichaelM.MirbabaMD
Psychiatry • Los Angeles, CAAddiction
Chief, Department of Addiction Medicine, Kaiser Permanente Los Angeles Medical Center
Dr. Mirbaba is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1505 N. Edgemont St, 3rd floor
Los Angeles, CA 90027Phone+1 323-783-8206
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Addiction Psychiatry, 2016 - 2017- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Psychiatry, 2012 - 2016
Harvard Medical SchoolClass of 2012
Harvard UniversityA.B., Magna cum laude
Certifications & Licensure
CA State Medical License 2013 - 2025- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Addiction Psychiatry
Clinical Trials
- Development of Ibudilast for Alcohol Use Disorder Start of enrollment: 2013 Dec 01
- Naltrexone for Individuals of East Asian Descent Start of enrollment: 2013 Dec 01
- Development of Ivermectin for Alcohol Use Disorders Start of enrollment: 2014 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsPharmacological Options for Smoking Cessation in Heavy-Drinking Smokers.Megan M. Yardley, Michael M. Mirbaba, Lara A. Ray
CNS Drugs. 2015-10-27
Professional Memberships
- Fellow
- American Academy of Addiction PsychiatryMember
- Member
- Member
- California Society of Addiction MedicineMember
- American Society of Clinical PsychopharmacologyMember
Other Languages
- French, Italian, Portuguese, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
